Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 40.78%

Shanghai Haoyuan Chemexpress Co., Ltd. Gross Profit Margin is 40.78% for the year ending December 31, 2023, a -20.73% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Shanghai Haoyuan Chemexpress Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 51.44%, a -4.94% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 54.12%, a -4.51% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 56.67%, a -0.88% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 57.18%, a 10.89% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years